| 2025-03-31 | +0.87 % |
|
| 2025-03-27 | +0.81 % |
|
| 2025-03-26 | -1.77 % |
|
| 2025-03-21 | -0.39 % |
|
| 2025-03-18 | -0.4 % |
|
| 2025-03-17 | +0.61 % |
|
| 2025-03-14 | +0.64 % |
|
| 2025-03-12 | -2.1 % |
|
| 2025-03-11 | +0.27 % |
|
| 2025-03-10 | -1.41 % |
|
| 2025-03-04 | -2.48 % |
|
| 2025-02-27 | -1.44 % |
|
| 2025-02-26 | -0.11 % |
|
| 2025-02-25 | +0.26 % |
- The article discusses PAVmed's completion of a $2.37 million private placement financing to support the development of its cancer care platform, Veris Health, which may positively impact GE HealthCare (GEHC) stock due to increased investor confidence in innovative cancer care technologies.
GEHC stock went up likely because of the optimism surrounding advancements in cancer care technology and the potential commercial success of Veris Health's new developments, which align with GEHC's strategic initiatives in theranostics and personalized medicine.
- GE HealthCare Technologies Inc. (NASDAQ:GEHC) shares increased by 0.26% following a favorable earnings report that exceeded estimates, strong institutional investor interest, and positive ratings upgrades from several research firms.
The increase in GE HealthCare's stock can be attributed to strong quarterly earnings that surpassed analysts' expectations and significant positive changes in institutional investments, alongside favorable analyst ratings which raised target prices for the stock.
- GE HealthCare Technologies (NASDAQ:GEHC) stock rose 0.26% following positive ratings from multiple research firms, including upgrades and increased price targets from Citigroup, Jefferies Financial Group, and Wells Fargo, which likely boosted investor confidence in the company's financial performance and future prospects.
- GE HealthCare Technologies Inc. (NASDAQ:GEHC) saw its stock rise by 0.26% following significant stake increases from institutional investors like D.A. Davidson & CO., along with positive analysts' ratings upgrades and strong recent earnings performance that surpassed expectations. The stock's increase can be attributed to growing institutional interest and favorable future earnings projections from analysts.
|
| 2025-02-14 | -1.36 % |
|
| 2025-02-13 | +8.82 % |
|
| 2025-02-11 | -0.54 % |
|
| 2025-02-10 | -0.16 % |
|
| 2025-02-07 | -1.03 % |
|
| 2025-02-04 | -0.66 % |
|
| 2025-01-31 | -1.4 % |
|
| 2025-01-24 | +0.58 % |
|
| 2025-01-10 | -1.74 % |
|
| 2025-01-06 | +1.49 % |
|
| 2025-01-03 | +2.73 % |
|
| 2025-01-02 | +0.26 % |
|
| 2024-12-31 | -0.53 % |
|
| 2024-12-27 | -0.25 % |
|
| 2024-12-19 | +0.44 % |
|
| 2024-12-18 | -2.73 % |
|
| 2024-12-12 | -1.35 % |
|
| 2024-12-10 | +0.56 % |
|
| 2024-12-09 | +0.81 % |
|
| 2024-12-06 | -0.4 % |
|
| 2024-12-04 | +0.53 % |
|
| 2024-12-03 | -0.61 % |
|
| 2024-12-02 | -0.17 % |
|
| 2024-11-25 | +0.27 % |
|
| 2024-11-22 | +0.54 % |
|
| 2024-11-21 | -3.42 % |
|
| 2024-11-19 | -0.24 % |
|
| 2024-11-18 | +1.17 % |
|
| 2024-11-15 | -1.4 % |
|
| 2024-11-12 | -0.55 % |
|
| 2024-11-07 | +1.79 % |
|
| 2024-11-01 | -0.46 % |
|
| 2024-10-31 | +0.17 % |
|
| 2024-10-30 | +2.26 % |
|
| 2024-10-29 | -0.77 % |
|
| 2024-10-28 | -2.82 % |
|
| 2024-10-24 | -0.44 % |
|
| 2024-10-23 | -0.02 % |
|
| 2024-10-22 | -0.55 % |
|
| 2024-10-18 | +0.57 % |
|
| 2024-10-17 | +0.67 % |
|
| 2024-10-14 | +0.65 % |
|
| 2024-10-11 | +0.86 % |
|
| 2024-10-10 | -0.57 % |
|
| 2024-10-09 | +0.09 % |
|
| 2024-10-08 | +0.7 % |
|
| 2024-10-07 | -1.49 % |
|
| 2024-10-04 | +1.71 % |
|
| 2024-10-03 | -1.27 % |
|
